Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target, ENSG00000234586 (also referred to as LOC100130801), is a pseudogene related to the functional Sjogren syndrome antigen B gene (SSB, also called La autoantigen). Unlike the protein-coding SSB gene, which encodes an RNA-binding protein involved in RNA metabolism and is an autoantigen in Sjögren’s syndrome and lupus, the pseudogene does not produce a functional protein and has no known biological activity or therapeutic relevance. Pseudogenes are considered non-functional sequences that arise from gene duplication or retrotransposition and typically do not participate in normal cellular processes[1][4][8]. Key points: - ENSG00000234586 is *not a therapeutic target*, *enzyme*, *receptor*, or functional protein[1][4]. - It is a non-coding pseudogene and does not have the known disease or drug interactions attributed to its functional gene counterpart[1][4][8]. - If you seek information on the *functional protein target* related to Sjogren syndrome antigen B, you should instead refer to the SSB (La protein, HGNC:11338, Entrez Gene:6741)[8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sjogren syndrome antigen B pseudogene.